Clinical Trial Update: A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the safety evaluation of CMTX-101 in people with cystic fibrosis in Phase 1/2; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• CMTX-101

Snippet

Sponsor: Clarametyx Biosciences, Inc. | Conditions: Persistent Infection, Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED